We are live on ! Find out more
CDMO

Avid Bioservices, Inc. Common Stock

Delisted

CDMO was delisted on the 4th of February, 2025.

70 hedge funds and large institutions have $36.3M invested in Avid Bioservices, Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 28 increasing their positions, 15 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

87% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 15

73% more call options, than puts

Call options by funds: $444K | Put options by funds: $257K

9% more capital invested

Capital invested by funds: $33.3M → $36.3M (+$3.03M)

3% less funds holding

Funds holding: 7270 (-2)

20% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 10

Holders
70
Holders Change
-2
Holders Change %
-2.78%
% of All Funds
2.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
28
Reduced
15
Closed
10
Calls
$444K
Puts
$257K
Net Calls
+$187K
Net Calls Change
-$169K
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
26
Renaissance Technologies
New York
$132K +$128K +13,617 New
RhumbLine Advisers
27
RhumbLine Advisers
Massachusetts
$128K -$3.36K -357 -3%
VKH
28
Virtu KCG Holdings
New York
$127K +$35.2K +3,745 +40%
Group One Trading
29
Group One Trading
Illinois
$125K -$53K -5,636 -30%
FHC
30
First Heartland Consultants
Missouri
$120K
Citigroup
31
Citigroup
New York
$120K +$112K +11,883 +2,664%
LTFS
32
Ladenburg Thalmann Financial Services
Florida
$118K +$92.7K +9,857 +431%
Susquehanna International Group
33
Susquehanna International Group
Pennsylvania
$108K -$16.5K -1,751 -14%
Millennium Management
34
Millennium Management
New York
$108K +$105K +11,110 New
GC
35
Guggenheim Capital
Illinois
$104K +$14.8K +1,573 +17%
FAAS
36
First Allied Advisory Services
California
$70K +$2.22K +236 +3%
ICAS
37
Investors Capital Advisory Services
Massachusetts
$65K +$13.7K +1,457 +28%
U
38
UBS
Switzerland
$63K +$56.3K +5,981 +1,131%
Goldman Sachs
39
Goldman Sachs
New York
$52K +$23.5K +2,495 +89%
Citadel Advisors
40
Citadel Advisors
Florida
$50K +$48.8K +5,186 New
Deutsche Bank
41
Deutsche Bank
Germany
$43K -$200K -21,300 -83%
RC
42
RegentAtlantic Capital
New Jersey
$41K
Barclays
43
Barclays
United Kingdom
$40K -$8.17K -868 -13%
PFPT
44
Pinnacle Financial Partners (Tennessee)
Tennessee
$28K
AllianceBernstein
45
AllianceBernstein
Tennessee
$27K -$58.9K -6,257 -70%
Morgan Stanley
46
Morgan Stanley
New York
$27K -$3.7K -393 -12%
AB
47
Amalgamated Bank
New York
$23K +$22.4K +2,379 New
GIA
48
Guyasuta Investment Advisors
Pennsylvania
$20K
LPL Financial
49
LPL Financial
California
$20K
Comerica Bank
50
Comerica Bank
Texas
$19K

CDMO Hedge Fund Activity: Q4 2013 in Review

70 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q4 2013, worth a combined $36.3M — up 9.1% from $33.3M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of CDMO and 8 opened new positions — a net loss of 2 holders — while 15 trimmed existing stakes and 28 added.

The largest buyer was Schroder Investment Management Group, opening a new position worth an estimated $1.16M. The largest seller was Deutsche Bank, cutting an estimated $200K.

  • 70 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q4 2013, down from 72 in Q3 2013.
  • Funds reported $36.3M of Avid Bioservices, Inc. Common Stock stock for Q4 2013, up 9.1% quarter-over-quarter.
  • 8 funds opened new Avid Bioservices, Inc. Common Stock positions in Q4 2013 and 10 closed out, a net change of -2 holders.
  • The largest Avid Bioservices, Inc. Common Stock buyer in Q4 2013 was Schroder Investment Management Group, an estimated $1.16M added.
  • The largest Avid Bioservices, Inc. Common Stock seller in Q4 2013 was Deutsche Bank, an estimated $200K sold.

Based on aggregated 13F filings for Q4 2013.